2-(4-bromo-1H-imidazol-1-yl)-N,N-dimethylethylamine | 879488-44-5

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-(4-bromo-1H-imidazol-1-yl)-N,N-dimethylethylamine
• 英文别名: 1H-Imidazole-1-ethanamine,4-bromo-N,N-dimethyl-；2-(4-bromoimidazol-1-yl)-N,N-dimethylethanamine
• CAS: 879488-44-5
• 化学式: C₇H₁₂BrN₃
• 分子量: 218.096
• InChiKey: VLYRGYRYQMSKDA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  21.1
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Substituted Biphenyl Derivative
  申请人：Kurata Hitoshi

  公开号：US20070275968A1

  公开（公告）日：2007-11-29

  The present invention relates to a biaryl derivative or a pharmacologically acceptable salt thereof having an excellent collagen-synthesis inhibition activity. A biaryl derivative having a structure represented by the following General Formula (I) or a pharmacologically acceptable salt thereof: wherein R 1 represents a C 6 -C 10 aryl group which is substituted with one to three group(s) each independently selected from the group consisting of a group defined by formula R-L-, a di-(C 1 -C 6 alkyl)amino group, a di-(C 1 -C 6 alkyl)aminosulfonyl group, a hydroxyaminocarbonyl group, and a halogen atom, and so on; R represents a C 1 -C 6 alkyl group, and so on; L represents a sulfonyl group, an aminosulfonyl group, or a sulfonylamino group, and so on; R 2 represents a hydrogen atom, and so on; A represents a group defined by formula (II), (III), or (IV); R 3 represents a C 1 -C 6 alkyl group, and so on; and R 4 represents a C 1 -C 6 alkyl group, and so on.

  本发明涉及一种具有优异的胶原合成抑制活性的双芳基衍生物或其药学上可接受的盐。一种具有以下通式（I）所表示的结构或其药学上可接受的盐的双芳基衍生物：其中，R1代表一个C6-C10芳基基团，该基团被一个或三个独立选择的基团所取代，所述基团由公式R-L-、二（C1-C6烷基）氨基基团、二（C1-C6烷基）氨基磺酰基团、羟胺基甲酰基团、卤素原子等组成；R代表C1-C6烷基基团等；L代表磺酰基、氨基磺酰基或磺酰胺基等基团；R2代表氢原子等；A代表由公式（II）、（III）或（IV）所定义的基团；R3代表C1-C6烷基基团等；R4代表C1-C6烷基基团等。
• SUBSTITUTED BIPHENYL DERIVATIVE
  申请人：Sankyo Company, Limited

  公开号：EP1798229A1

  公开（公告）日：2007-06-20

  The present invention relates to a biaryl derivative or a pharmacologically acceptable salt thereof having an excellent collagen-synthesis inhibition activity. A biaryl derivative having a structure represented by the following General Formula (I) or a pharmacologically acceptable salt thereof: wherein R1 represents a C6-C10 aryl group which is substituted with one to three group(s) each independently selected from the group consisting of a group defined by formula R-L-, a di-(C1-C6 alkyl)amino group, a di-(C1-C6 alkyl)aminosulfonyl group, a hydroxyaminocarbonyl group, and a halogen atom, and so on; R represents a C1-C6 alkyl group, and so on; L represents a sulfonyl group, an aminosulfonyl group, or a sulfonylamino group, and so on; R2 represents a hydrogen atom, and so on; A represents a group defined by formula (II), (III), or (IV); R3 represents a C1-C6 alkyl group, and so on; and R4 represents a C1-C6 alkyl group, and so on.

  本发明涉及一种具有优异胶原合成抑制活性的生物芳基衍生物或其药理学上可接受的盐。一种具有下通式（I）所代表结构的生物芳基衍生物或其药理学上可接受的盐： 其中 R1代表C6-C10芳基，该芳基被一至三个各自独立地选自式R-L-定义的基团、二-(C1-C6烷基)氨基、二-(C1-C6烷基)氨基磺酰基、羟基氨基羰基和卤原子等组成的组取代；R 代表 C1-C6 烷基，以此类推；L 代表磺酰基、氨磺酰基或磺酰氨基，以此类推；R2 代表氢原子，以此类推；A 代表式（II）、（III）或（IV）定义的基团；R3 代表 C1-C6 烷基，以此类推；R4 代表 C1-C6 烷基，以此类推。